Are you a new member? Sign up now
Login area
| Sign up
close
STELARA - 130mg - 1
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AC05 | BioTech | Ustekinumab - 130mg | 9150 | 59017/1 | STELARA | 130mg | 1 | Injectable concentrate for solution | Infusion | Abela Frères S.A.L. | Cilag AG | Switzerland | 66,388,822 L.L | 10.71 | E1 | Janssen Cilag International NV | Belgium | 13/01/20 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AC05 | BioTech | Ustekinumab - 130mg | 9150/388 | 59017/1 | STELARA | 130mg | 1 | Injectable concentrate for solution | Infusion | Abela Frères S.A.L. | Cilag AG | Switzerland | L.L | 10.71 | E1 | Janssen Cilag International NV | Belgium | 13/01/20 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2026